Unexpected voriconazole toxicity due to nirmatrelvir/ritonavir: a case report on drug-drug interaction and the role of therapeutic drug monitoring
Voriconazole is a triazole antifungal used for invasive fungal infections, particularly invasive aspergillosis. Its metabolism is primarily mediated by CYP2C19, with CYP3A4 and CYP2C9 also involved. Nirmatrelvir/ritonavir, an oral antiviral for COVID-19, inhibits CYP isoforms potentially altering th...
Saved in:
| Main Authors: | J. López-Hernández, A. B. Guisado-Gil, M. Mejías-Trueba, L. Herrera-Hidalgo, F. J. Reina-Martínez, M. V. Gil-Navarro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1616061/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Different Tacrolimus Formulations in the Early Post-Liver Transplant Period: A Scoping Review
by: Paloma Barriga-Rodríguez, et al.
Published: (2025-05-01) -
Plasma concentration of voriconazole under concomitant use of nirmatrelvir/ritonavir in patients with COVID-19: a multicenter retrospective study
by: Hao Shi, et al.
Published: (2025-08-01) -
Effect of inflammation on voriconazole levels in patients with invasive pulmonary aspergillosis
by: Pinar Bakir Ekinci, et al.
Published: (2024-10-01) -
Therapeutic drug monitoring of voriconazole and the impact of inflammation on plasma trough concentrations in children
by: Lin Hu, et al.
Published: (2025-06-01) -
Thermolabile drugs: pharmacist intevention as a guarantee of cold chain maintenance
by: I. Ricote-Lobera, et al.
Published: (2014-05-01)